SECAUCUS, N.J., Nov. 18, 2020 /PRNewswire/ -- Quest
Diagnostics (NYSE: DGX), the world's leading provider of
diagnostic information services, today announced that its Board of
Directors declared a quarterly cash dividend of $0.56 per
share, payable on February 3, 2021 to shareholders
of record of Quest Diagnostics common stock on January
20, 2021.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health
outcomes. Derived from the world's largest database of clinical lab
results, our diagnostic insights reveal new avenues to identify and
treat disease, inspire healthy behaviors and improve health care
management. Quest Diagnostics annually serves one in three adult
Americans and half the physicians and hospitals in the United States, and our 47,000 employees
understand that, in the right hands and with the right context, our
diagnostic insights can inspire actions that transform lives.
www.QuestDiagnostics.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-301176537.html
SOURCE Quest Diagnostics